Redhill Biopharma Ltd. - ADR

Redhill Biopharma Ltd. - ADR

RDHL

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.14M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Redhill Biopharma Ltd. - ADRRedhill Biopharma Ltd. - ADR-0.3--218%0.20.3
$0.86

Current Fair Value

14.5% downside

Overvalued by 14.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.14 Million
Enterprise Value$241,857.00
Dividend Yield$- (-)
Earnings per Share$0
Beta5.04
Outstanding Shares1,803,002

Return

Return on Equity-218.21%ROE
Return on Assets-36.74%
Return on Invested Capital-133.64%

Valuation & Multiples

P/E Ratio-0.27P/E Ratio
PEG-0.79PEG
Price to Sales0.2Price to Sales
Price to Book Ratio0.5Price to Book Ratio
Enterprise Value to Revenue0.03
Enterprise Value to EBIT-0.03
Enterprise Value to Net Income-1
Total Debt to Enterprise4.42
Debt to Equity0.25Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 9, 2026
EPS Estimate
$-435.00
Average shareholder expectation
Revenue Estimate
$22.70 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
$-352.86
Average shareholder expectation
Revenue Estimate
$24.29 M
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Redhill Biopharma

CEO: Dror Ben-Asher